Clinical trial
Strategy to Adapt Botulinum Toxin Doses in Dystonia
NCT06386848 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Strategy to Adapt Botulinum Toxin Doses in Dystonia
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2024
- Completion date
- June 1, 2024
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.